martes, 27 de diciembre de 2022

Eisai, Biogen's new Alzheimer's drug should be priced below Aduhelm - report | Reuters

Eisai, Biogen's new Alzheimer's drug should be priced below Aduhelm - report | Reuters

No hay comentarios: